Wed, Jul 23, 2014, 7:30 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Stryker Corporation Message Board

andy55q 67 posts  |  Last Activity: 3 hours ago Member since: Feb 2, 2006
  • WHO GETS SEPSIS? Anyone can get sepsis, but the risk is higher in: people with weakened immune systems infants and children elderly people people with chronic illnesses, such as diabetes, AIDS, cancer, and kidney or liver disease people suffering from a severe burn or physical trauma. HOW MANY PEOPLE GET SEPSIS? CDC’s National Center for Health Statistics estimates that, based upon information collected for billing purposes, the number of times people were in the hospital with sepsis or septicemia (another word for sepsis) increased from 621,000 in the year 2000 to 1,141,000 in 2008. (1) Between 28 and 50 percent of people who get sepsis die. (2) The number of cases of sepsis each year has been going up in the United States. This could be because of the following reasons: the population is aging people have more chronic illnesses, people are getting more invasive procedures, immunosuppressive drugs, chemotherapy, and organ transplants, increasing antibiotic resistance and increasing awareness and tracking of sepsis.

    Sentiment: Buy

  • andy55q andy55q Apr 27, 2014 11:58 AM Flag

    What is sepsis according to Dr.Kevin Tracey.


    Sepsis occurs when molecules released into the bloodstream to fight an injury or infection trigger inflammation throughout the body. Inflammation is necessary for maintaining good health – without inflammation, wounds and infections would never be controlled or heal. However, persistent and constant inflammation often results in organ dysfunction or damage, leading to death – 28 to 50 percent of people who suffer from sepsis die from the condition. In addition to the toll in human lives, sepsis costs healthcare systems billions of dollars each year – much of the costs attributed to expenses incurred during weeks or months-long stays in intensive care units.

    Sentiment: Buy

  • andy55q andy55q Apr 27, 2014 11:52 AM Flag

    "But swine flu, avian flu, SARS, H7N9, MERS, and most notably, the great flu pandemic of 1918 are different animals. They don't kill through pneumonia. They kill you by unleashing a cytokine storm, which means that it is your own immune system that kills you."
    H7N9 & MERS - CoV Pandemic Scares | Natural Health Blog
    Date: 06/15/2013 Written by: Jon Barron

    Sentiment: Buy

  • andy55q andy55q Apr 26, 2014 9:07 PM Flag

    CytoSorbents, Inc. Comments on CytoSorb(TM) and the Swine Flu Outbreak
    MONMOUTH JUNCTION, NJ -- (MARKET WIRE) -- 05/06/09 -- CytoSorbents, Inc. comments on the current swine flu outbreak and highlights the urgent need for improved therapies for influenza and other respiratory viruses. In particular, potentially virulent pathogens such as avian flu (H5N1 subtype), swine flu (H1N1 subtype), and the SARS virus can quickly kill a large percentage of those infected. According to the Centers for Disease Control, normal seasonal influenza afflicts 15-60 million people in the United States each year, hospitalizing more than 200,000, and directly contributing to the deaths of 36,000 people annually. Although these numbers are significant, in contrast, the 1918 Spanish influenza pandemic infected an estimated one third of the world population, killing nearly 50 million people. Highly virulent flu strains have the ability to evade neutralization by the immune system, leading to a prolonged and intense infection that can lead to severe sepsis and death. Although the virus itself has destructive capability, the body's own aggressive immune response and "cytokine storm" are recognized as leading drivers of mortality in these patients. Cytokines are normally helpful proteins that control the immune system. In severe sepsis due to influenza, however, cytokines are often produced in excessive, toxic quantities leading to acute respiratory distress syndrome (severe lung inflammation), organ failure, and numerous complications that often result in death. Anti-viral therapy such as Tamiflu(TM), Relenza(TM) and amantadine may slow viral infection if used early enough and if resistance is not an issue. But given the major role that cytokine storm is believed to play in the pathogenesis of these deadly viruses, more options are needed to directly address this critical issue now.

    Sentiment: Buy

  • General Sources Saturday 26th April, 2014
    News ) stock volume surged Apr. 24, with 1,774,353 shares changing hands, higher than its three-month average volume of 1,703,870 shares. The uptick in stock volume is tied in part to the Monmouth, N.J.-based medical device company's recent announcement that it has expanded the distribution of its CytoSorb(R) extracorporeal cytokine filter to the Middle East. The product will now be sold to Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman (the Gulf Cooperation Council or GCC) and Yemen, Iraq and Jordan. This was made possible through an exclusive agreement with Techno O...

    Sentiment: Buy

  • Reply to

    5 More Deaths MERS Virus total now 92

    by berthabluefish Apr 26, 2014 9:32 AM
    andy55q andy55q Apr 26, 2014 11:25 AM Flag

    Dr. Margaret Chan, director-general of the World Health Organization
    Why a Saudi Virus Is Spreading Alarm
    Author: Laurie Garrett, Senior Fellow for Global Health
    May 29, 2013
    Dr. Margaret Chan, director-general of the World Health Organization, closed the annual World Health Assembly this week [May 27] sounding alarm about a new SARS-like virus circulating primarily in Saudi Arabia.

    "My greatest concern right now is the novel coronavirus," Chan warned the representatives of two hundred nations gathered in Geneva. "We do not know where the virus hides in nature. We do not know how people are getting infected. Until we answer these questions, we are empty-handed when it comes to prevention."

    Sentiment: Buy

  • Reply to

    Biocon Call

    by mak.orlfl Apr 25, 2014 8:22 AM
    andy55q andy55q Apr 25, 2014 8:43 AM Flag

    Corporate
    Milestones
    Commercial Launch:
    o Alzumab™, our indigenously developed first-in-class anti-CD6 indicated
    for Psoriasis
    o CANMAb ™, World’s first biosimilar trastuzumab to be commercialized
    Strategic Tie ups with:
    o Cytosorbents: Cytosorb for sepsis management
    o Quark Pharma : siRNA based novel therapeutics
    o Advaxis Inc: Novel cancer immunotherapy
    Syngene :
    o successfully cleared the first US FDA audit of its quality systems
    o Inauguration of the Baxter Global Research Centre
    Ranked #6 in the Top 20 global biotech employer list (2013) by the
    Science Magazine

    Sentiment: Buy

SYK
81.81-0.08(-0.10%)Jul 23 4:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.